Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, agosto 31
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Bristol-Myers Squibb Co
BMY
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$66.58
-0.37
-0.55%
In chiusura: Aug 27, 5:00 PM EST
$66.30
-0.65
-0.97%
Pre-mercato: 7:48 AM EST
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Dividendi
Confronta
Opzioni
Bristol-Myers Squibb Financials
Bristol-Myers Squibb (BMY) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Oil Sinks 6%, Nasdaq 100 Rallies On Iran Talks: Stock Market Today
Crude tumbles nearly 6% after Trump cancels a strike on Iran, lifting the S&P 500 1.3% and the Russell 2000 1.5% at midday Monday.
Piero Cingari
Bristol-Myers Boosts 2026 Guidance on Portfolio Strength
Bristol-Myers beats Q2 earnings and revenue estimates, driven by growth drugs, while raising its full-year 2026 sales and profit outlook.
Vandana Singh
PRO
Bristol-Myers Squibb Raises FY2026 Adj EPS Guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 Est; Raises FY2026 Sales Guidance from $46.000B-$47.500B to $49.000B-$50.000B vs $47.472B Est
Bristol-Myers Squibb (NYSE:BMY) raises FY2026 Adj EPS guidance from $6.05-$6.35 to $6.75-$7.00 vs $6.34 analyst estimate. Raises FY2026 sales outlook from $46.000 billion-$47.500 billion to $49.000 billion-$50.000
Benzinga Newsdesk
PRO
Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate
Benzinga Newsdesk
Dow Records Worst Session Since April 2025; Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone
The CNN Money Fear and Greed index showed a sharp decline in market sentiment as stocks fell and oil prices rose due to US-Iran tensions.
Avi Kapoor
Apple, Microsoft And 3 Stocks To Watch Heading Into Thursday
U.S. stock futures trading higher, focus on Apple, Microsoft, Amazon earnings. Meta posts mixed results, Bristol-Myers Squibb to release earnings.
Avi Kapoor
Privacy Manager